Skip to main content
Equibles
NEPH logo

NEPH

Nephros Inc
$3.63 +0.13 (+3.71%) At close · Jul 10
Market Cap
$39.41M
Shares
10,856,546

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.63 Open$3.57 Day$3.37–3.63 52W$2.66–6.42 Avg vol 30d11K Short int32K · 0.3% float · 2.5d Short vol21% Last earningsMay 7, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 7
Up next
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 7, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 15 · calm Equity put/call 0.55
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −12%
      below
      Price vs 50-day avg +7%
      above
      RSI (14) 57
      neutral
      MACD trend Positive
      52-week position 26%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +13%
      trailing
      6-month return −17%
      trailing
      YTD return −26%
      this year
      Relative strength −26%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $3 › 200d $4 — 200d above 50d
      Institutional flow Distributing
      -23% holders QoQ · +3 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      0.29% of float · ▲ +59.6% MoM · 2.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      27 holders — mid 3-yr range
      Squeeze score 59
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +33%
      Y/Y
      Gross margin 62%
      expanding
      EPS growth +1000%
      Y/Y
      Free cash flow $1.5M
      Valuation P/E 51.9
      in line
      Balance sheet $5.3M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 91%
      annualized · 1-yr
      Max drawdown −53%
      past year
      ATR 6.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −12% Bearish
      Price vs 50-day avg
      +7% Bullish
      RSI (14)
      57 Neutral
      MACD trend
      Positive Bullish
      52-week position
      26% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $3 › 200d $4 — 200d above 50d
      Institutional flow Distributing
      -23% holders QoQ · +3 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      0.29% of float · ▲ +59.6% MoM · 2.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      27 holders — mid 3-yr range
      Price context
      position in its 52-week range
      52-wk low $3 Now $4 · 26% 52-wk high $6
      vs 200-day avg -12% vs 50-day avg +7%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Adjusted EBITDA non-GAAP $206,000 first quarter of 2026 —
      Adjusted EBITDA Income non-GAAP $667K Three Months Ended March 31, 2025 —
      active customer sites 1,676 Q1 FY2026 call —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      NEPH
      Nephros Inc
      this stock
      		$39.41M -25.6% +32.7% 51.9 0.3%
      ISRG
      Intuitive Surgical Inc
      		 $144.07B -28.2% +20.5% 49.4 2.1%
      MDLN
      Medline Inc.
      		 $53.91B -2.3% +11.5% — 2.8%
      BDX
      Becton Dickinson & Co
      		 $41.87B +0.9% +8.2% 57.7 4.1%
      ALC
      Alcon Inc
      		 $33.07B -14.0% +10.5% — 2.1%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      27
      % held
      49.5%
      Net QoQ
      +68.0K sh
      Top holder
      WEXFORD CAPITAL LP
      Held Float
      View
      Held by Funds
      Fund positions
      13
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      31.8K
      Days to cover
      2.5d
      Change
      +11.9K sh
      View
      Short Volume
      Short vol %
      21%
      As of
      Jul 10, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      961
      Value
      $3.5K
      As of
      Jun 4, 2026
      View
      Off-Exchange
      Off-exchange %
      49.7%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $18.8M
      Net income (FY)
      $1.2M
      EPS diluted
      $0.11
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 15, 2026
      This year
      6
      View
      Exempt Offerings
      Offering
      $2.4M
      Filed
      Sep 7, 2021
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 7, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      NEPH +6.8% +13.4% -17.1% +1.7% -25.6%
      SPY +1.4% +4.1% +9.1% +1.1% +10.7%
      vs SPY +5.4% +9.4% -26.2% +0.6% -36.3%
      Key facts CIK 1196298 CUSIP 640671400 13F (30d) 1 filings 1 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)